Hybrid Imaging Market Size & Growth Forecast 2027–2036, By Segments (End Use, Type, Application), Regional Demand Trends (North America, Asia Pacific, Europe), Key Country Insights (U.S., Japan, South Korea, Germany, France, Italy), and Competitive Landscape
Market Size and Growth Outlook
Hybrid Imaging Market size was assessed at USD 9.4 billion in 2026 and is poised to grow at a 5.8% CAGR between 2027 and 2036, attaining USD 16.52 billion by 2036. The industry revenue for 2027 is estimated at USD 9.86 billion.
Get more details on this report
Request Free Sample ReportHybrid Imaging Market Intelligence Snapshot
Regional Market Dynamics
- North America accounted for a 44.52% market share in 2026, supported by advanced diagnostic infrastructure and widespread use of hybrid imaging systems across oncology, cardiology, and neurology workflows.
- Asia Pacific is projected to grow at a 7.01% CAGR as healthcare providers expand advanced diagnostic equipment installations and integrate hybrid imaging into more complex clinical assessments.
Segment Momentum
- PET/CT Systems held a 34.24% share in 2026 due to their established clinical adoption, broad installed base, and routine use in combining metabolic and anatomical imaging across high-volume diagnostic workflows.
- Diagnostic Imaging Centers are growing fastest because they offer specialized imaging services, greater scheduling flexibility, and higher workflow efficiency, meeting rising demand for faster outpatient diagnostic access.
Market Expansion Drivers
- Rising prevalence of cancer and cardiovascular diseases driving multimodal diagnostic imaging demand.
- Expansion of outpatient imaging centers improving access to advanced diagnostic technologies.
- Government funding and research initiatives accelerating adoption of advanced imaging modalities.
Leading Market Participants
- Prominent companies in the hybrid imaging market include GE HealthCare Technologies Inc. (United States), Siemens Healthineers AG (Germany), Koninklijke Philips N.V. (Netherlands), Canon Medical Systems Corporation (Japan), United Imaging Healthcare Co., Ltd. (China), Digirad Corporation (United States), Bruker Corporation (United States), Mediso Medical Imaging Systems (Hungary).
Global Market Forecast Snapshot
Market Outlook
- 2026 Market Size: USD 9.4 billion
- 2027 Estimated Market Size: USD 9.86 billion.
- Projected Market Size: USD 16.52 billion by 2036
- Growth Forecast: 5.8% CAGR (2027-2036)
Regional and Segment Outlook
- Leading Regional Market: North America
- High-Growth Regional Hub: Asia Pacific
- Core Revenue Segment: Hospitals (End Use) | PET/CT Systems (Type) | Oncology (Application)
- Emerging Opportunity Segment: Diagnostic Imaging Centers (End Use) | PET/MR Systems (Type) | Oncology (Application)
Market Growth Drivers and Industry Trends
Rising prevalence of cancer and cardiovascular diseases driving multimodal diagnostic imaging demand
The increasing burden of cancer and cardiovascular diseases is creating greater demand for diagnostic technologies capable of providing detailed and complementary clinical information. Hybrid imaging market growth is supported by the ability of multimodal systems to combine functional, metabolic, anatomical, or structural information within a coordinated diagnostic workflow, helping clinicians evaluate complex conditions more comprehensively. As disease management increasingly depends on accurate diagnosis, staging, treatment planning, and monitoring, healthcare providers are placing greater emphasis on imaging approaches that can improve lesion characterization and support more informed clinical decisions.
Expansion of outpatient imaging centers improving access to advanced diagnostic technologies
The development of outpatient imaging facilities is broadening access to sophisticated diagnostic services beyond major hospitals and specialized medical institutions. For the hybrid imaging market, this expansion creates additional opportunities for advanced systems to be deployed closer to patients, particularly as healthcare delivery shifts toward convenient and lower-complexity outpatient settings. Increased availability of dedicated imaging centers can also support earlier diagnostic evaluation, improve referral pathways, and enable healthcare providers to manage growing imaging volumes while reducing reliance on centralized hospital-based services.
Government funding and research initiatives accelerating adoption of advanced imaging modalities
Public-sector investment in healthcare infrastructure, medical research, and diagnostic innovation can create a favorable environment for the adoption of advanced imaging technologies. Government funding programs and research initiatives can help healthcare institutions improve imaging capabilities while supporting clinical studies that demonstrate the value of multimodal diagnostic approaches. Such initiatives can also strengthen collaboration among healthcare providers, research institutions, and technology developers, encouraging the evaluation and integration of advanced imaging modalities into diagnostic and disease-management pathways.
| Growth Driver | Impact on CAGR | Regulatory Influence | Geographic Relevance | Adoption Rate | Impact Timeline |
|---|---|---|---|---|---|
| Rising prevalence of cancer and cardiovascular diseases driving multimodal diagnostic imaging demand | 2.20% | High | North America, Europe | High | Near Term |
| Expansion of outpatient imaging centers improving access to advanced diagnostic technologies | 2.00% | High | North America, Asia Pacific | High | Mid Term |
| Government funding and research initiatives accelerating adoption of advanced imaging modalities | 1.80% | High | North America, Europe | Medium | Mid Term |
Unlock insights tailored to your business with our bespoke market research solutions.
Click to get your customized report now.
Regional Demand Dynamics
North America (Largest Region)
North America held the largest share of the hybrid imaging market in 2026, supported by advanced healthcare infrastructure, strong adoption of sophisticated diagnostic technologies, and substantial investment in medical imaging capabilities. The region benefits from well-established hospital and diagnostic networks, a high level of clinician awareness, and growing demand for imaging modalities that combine anatomical and functional information to improve diagnostic precision. Continued emphasis on early disease detection, personalized treatment planning, and workflow efficiency is encouraging healthcare providers to adopt integrated imaging solutions. In addition, established reimbursement frameworks and ongoing technological development are helping sustain demand for advanced hybrid imaging systems.
Asia Pacific (Fastest-Growing Region)
Asia Pacific is emerging as the fastest-growing regional market, driven by expanding healthcare infrastructure, increasing investments in diagnostic facilities, and rising demand for advanced medical technologies. Growing healthcare access across developing economies is creating opportunities for broader deployment of hybrid imaging systems, while increasing awareness of early diagnosis is supporting demand for sophisticated diagnostic procedures. The expansion of hospitals and specialized medical centers, coupled with improving availability of trained healthcare professionals, is strengthening the region's capacity to adopt advanced imaging technologies. Government efforts to modernize healthcare systems and rising private-sector investment are also contributing to the region's accelerating market development.
| Parameter | North America | Asia Pacific | Europe | Latin America | MEA |
|---|---|---|---|---|---|
| Innovation Hub i Scale Nascent Developing Advanced | |||||
| Cost-Sensitive Region i Scale Low Medium High | |||||
| Regulatory Environment i Scale Restrictive Neutral Supportive | |||||
| Demand Drivers i Scale Weak Moderate Strong | |||||
| Development Stage i Scale Emerging Developing Developed | |||||
| Adoption Rate i Scale Low Medium High | |||||
| New Entrants / Startups i Scale Sparse Moderate Dense | |||||
| Macro Indicators i Scale Weak Stable Strong |
Key Country Insights
Germany 🇩🇪
Precision Diagnostic IntegrationGermany emphasizes hybrid imaging technologies that support early disease detection and multidisciplinary clinical decision-making. German hospitals continue modernizing imaging infrastructure while strengthening research collaborations focused on advanced molecular imaging applications.
France 🇫🇷
Oncology Imaging AdvancementFrance is expanding hybrid imaging deployment to improve cancer diagnosis, treatment planning, and disease monitoring. French healthcare providers are focusing on coordinated imaging services and technology upgrades that enhance clinical consistency and patient management.
Italy 🇮🇹
Hospital Modernization SupportItaly is incorporating hybrid imaging systems into hospital modernization initiatives aimed at improving diagnostic quality. Italian healthcare providers are prioritizing equipment renewal, specialist training, and integrated imaging workflows for complex disease assessment.
Japan 🇯🇵
High-Resolution Imaging FocusJapan prioritizes hybrid imaging solutions that deliver enhanced diagnostic accuracy with optimized patient workflows. Japanese healthcare institutions are integrating next-generation imaging platforms with digital health systems to improve clinical efficiency and personalized care.
South Korea 🇰🇷
Digital Imaging ExpansionSouth Korea is strengthening hybrid imaging capabilities through investments in smart hospitals and advanced diagnostic technologies. South Korean medical centers are adopting integrated imaging platforms supported by AI-enabled interpretation and connected healthcare infrastructure.
United States 🇺🇸
Clinical Imaging InnovationThe U.S. hybrid imaging market is expanding adoption of integrated PET/CT, PET/MRI, and SPECT/CT systems across oncology, cardiology, and neurology. U.S. healthcare providers are investing in AI-assisted image analysis and workflow optimization to improve diagnostic precision and operational efficiency.
Segment Leadership and Growth Trends
Hybrid Imaging Market Share (%), by End Use, 2026
Go beyond the chart, access full insights & data tables
Request Free Sample ReportEnd Use Segment Analysis: Hospitals (Largest Segment) vs Diagnostic Imaging Centers (Fastest-Growing Segment)
Hospitals led the hybrid imaging market with a 56.18% share in 2026, supported by their comprehensive diagnostic infrastructure, multidisciplinary clinical teams, and ability to integrate advanced imaging into broader patient-care pathways. Hybrid imaging systems combine complementary imaging modalities to provide more detailed anatomical and functional information, making them valuable across complex diagnostic and treatment planning applications. Hospitals also benefit from established imaging departments and access to specialist services, reinforcing their strong position in hybrid imaging adoption.
Diagnostic imaging centers are experiencing increasing demand as healthcare delivery becomes more specialized and diagnostic services expand beyond traditional hospital settings. These centers can provide focused imaging services with streamlined workflows and dedicated diagnostic capabilities, supporting greater accessibility to advanced imaging technologies. Rising demand for accurate disease characterization, earlier diagnosis, and specialized outpatient imaging is encouraging greater deployment of hybrid imaging systems within diagnostic imaging centers.
Type Segment Analysis: PET/CT Systems (Largest Segment) vs PET/MR Systems (Fastest-Growing Segment)
PET/CT systems accounted for 34.24% of the hybrid imaging market in 2026, reflecting their established combination of metabolic and anatomical imaging capabilities. PET/CT supports comprehensive assessment of disease activity and anatomical location, particularly in applications where precise lesion characterization and treatment planning are important. Its broad clinical utility, established workflow integration, and familiarity among healthcare professionals continue to underpin its leading position within hybrid imaging.
PET/MR systems are gaining momentum as healthcare providers increasingly seek advanced imaging solutions that combine metabolic information with high-quality soft-tissue visualization. The technology can be particularly valuable where detailed tissue characterization and functional assessment are required while limiting exposure to ionizing radiation from CT. Continued advances in imaging technology, growing interest in comprehensive diagnostic information, and demand for more specialized imaging approaches are supporting increasing adoption of PET/MR systems.
| Segment | Sub-Segment | Largest Segment | Fastest Growing |
|---|---|---|---|
| End Use | Hospitals, Diagnostic Imaging Centers, Others | Hospitals | Diagnostic Imaging Centers |
| Type | PET/CT Systems, SPET/CT Systems, PET/MR Systems, OCT/Fundus Imaging System, Others | PET/CT Systems | PET/MR Systems |
| Application | Oncology, Ophthalmology, Cardiology, Brain & Neurology, Others | Oncology | Oncology |
Competitive Landscape and Market Positioning
Prominent players in the hybrid imaging market:
1. GE HealthCare Technologies Inc. (United States)
2. Siemens Healthineers AG (Germany)
3. Koninklijke Philips N.V. (Netherlands)
4. Canon Medical Systems Corporation (Japan)
5. United Imaging Healthcare Co. Ltd. (China)
6. Digirad Corporation (United States)
7. Bruker Corporation (United States)
8. Mediso Medical Imaging Systems (Hungary)
The hybrid imaging market is advancing through integration of multi-modality diagnostic systems that improve clinical accuracy and workflow efficiency. Continuous innovation is enabling more comprehensive imaging solutions for complex disease assessment. Collaborative development initiatives are further strengthening technological convergence across imaging platforms.
| Company | Market Share | Company Revenue | Revenue CAGR (%) | Product Portfolio | Geographic Presence | Innovation / R&D Focus | Strategic Developments |
|---|---|---|---|---|---|---|---|
| GE HealthCare Technologies Inc. (United States) | |||||||
| Siemens Healthineers AG (Germany) | |||||||
| Koninklijke Philips N.V. (Netherlands) | |||||||
| Canon Medical Systems Corporation (Japan) | |||||||
| United Imaging Healthcare Co. Ltd. (China) | |||||||
| Digirad Corporation (United States) | |||||||
| Bruker Corporation (United States) | |||||||
| Mediso Medical Imaging Systems (Hungary). |
Industry Development/News
| Company Name | Date | Key Development |
|---|---|---|
| Siemens Healthineers | Oct-24 | Siemens Healthineers secured FDA clearance for six systems within its Artis interventional imaging portfolio. Integrating the Optiq AI imaging chain, these systems provide enhanced image quality and workflow automation for image-guided procedures. This launch expands the company's competitive footprint in advanced hybrid imaging, focusing on operational efficiency and diagnostic precision for clinical environments. |
| GE HealthCare | Oct-24 | GE HealthCare expanded its strategic partnership with Stanford Radiology to launch a Center of Excellence for radiology innovation. The collaboration focuses on integrating molecular imaging, CT, MR, and interventional radiology with AI and pharmaceutical diagnostics. This effort is designed to accelerate the development of next-generation hybrid imaging technologies and clinical workflows through co-innovation and data-driven research. |
| Erasmus MC | Sep-24 | Erasmus MC led the AMICE consortium in securing €19.6 million in funding to develop advanced multimodal imaging infrastructure. This initiative aims to accelerate the commercialization and integration of next-generation biomedical imaging technologies. By building a robust research and development ecosystem, the project strengthens the foundational infrastructure for future breakthroughs in hybrid and multimodal imaging applications. |
| LAITEK | Jul-24 | LAITEK launched an Advanced Hybrid Migration Service to address medical imaging data management challenges. The service is engineered to lower capital and operational costs associated with migrating, storing, and accessing large-scale diagnostic datasets. By streamlining the lifecycle of clinical information, the solution enhances data interoperability and accessibility for health systems utilizing complex hybrid imaging environments. |
| ZimVie Inc. | Sep-23 | The FDA granted ZimVie an Investigational Device Exemption (IDE) for its Mobi-C Cervical Disc hybrid application, authorizing a clinical study for simultaneous cervical disc arthroplasty and anterior cervical discectomy and fusion. This trial allows the company to evaluate a hybrid surgical approach at adjacent levels, potentially expanding the clinical application and market positioning of its spinal implant technology. |
| Blue Earth Diagnostics | May-23 | The FDA approved Flotufolastat Fluorine-18 injection, the first radiohybrid PSMA-targeted PET imaging agent for detecting prostate cancer. This regulatory milestone provides a novel diagnostic tool for clinical assessment and treatment monitoring. The introduction of radiohybrid technology signifies a material advancement in oncological imaging capabilities, improving diagnostic accuracy for patients with suspected prostate cancer recurrence or metastasis. |
Customize Your Report
Explore examples of how this report can be tailored to different research needs, including custom segments, additional topics or chapters, and related reports. Click a section of the wheel or its numbered marker to explore the available options.
Hybrid Imaging Market — Custom Segments
| Segment | Sub-Segment |
|---|---|
| Ownership Model | Public Healthcare Institutions, Private Healthcare Institutions, Academic & Research Institutions |
| Reimbursement Model | Public Insurance, Private Insurance, Self-Pay & Out-of-Pocket |
| Imaging Workflow | Standalone Imaging, Integrated Diagnostic Workflow, Image-Guided Intervention |
Hybrid Imaging Market — Custom
| Custom Chapter | Custom Details |
|---|---|
| Multimodal Diagnostic Workflow Transformation |
|
| Hybrid Imaging Adoption Barriers and Acceleration Strategies |
|
| Clinical Application Expansion Opportunities |
|
Need a different cut of the data?
Request Custom ResearchHow large is the hybrid imaging market?
What is the expected industry size of hybrid imaging by 2036?
How are rising cancer and cardiovascular cases influencing purchasing decisions in the hybrid imaging market?
Why is the expansion of outpatient imaging centers accelerating hybrid imaging adoption?
Why do PET/CT systems lead the hybrid imaging market?
Why are diagnostic imaging centers the fastest-growing end-use segment in the hybrid imaging market?
Why does North America lead the hybrid imaging market?
What is driving hybrid imaging market growth in Asia Pacific?
Who holds a significant market share in the hybrid imaging landscape?
Our Clients
"The reports offered a comprehensive view of the Food and Beverage landscape, covering market trends, consumer behavior, and competitive dynamics."
"Our experience in acquiring market research reports has been outstanding — the depth of analysis and actionable insights have proven invaluable."
"Fundamental Business Insights demonstrated a keen understanding of our business needs, delivering reports tailored to our specific objectives."
Our Research Team & Methodology
Every Fundamental Business Insights report is built by a dedicated vertical research team, validated through a structured primary-and-secondary methodology, and reviewed for accuracy before it reaches you.
Research Team Overview
Prepared by the Healthcare & Medical Devices Research Team
Delivery
Published
Demand
Available
Support
Trust & Compliance
Research Domains
10 coverage areasResearch Intelligence
| Source | Why It Matters | Reference |
|---|---|---|
| World Health Organization (WHO) | Global health statistics, disease burden, healthcare policies | www.who.int |
| U.S. Food & Drug Administration (FDA) | Medical devices, pharmaceuticals, diagnostics, approvals | www.fda.gov |
| European Medicines Agency (EMA) | Pharmaceutical approvals and regulatory guidance in Europe | www.ema.europa.eu |
| Centers for Disease Control and Prevention (CDC) | Disease surveillance, public health, epidemiology | www.cdc.gov |
| National Institutes of Health (NIH) | Biomedical research, clinical studies, funding | www.nih.gov |
| National Center for Biotechnology Information (NCBI) | Biomedical databases, PubMed, genomics | www.ncbi.nlm.nih.gov |
| PubMed | Peer-reviewed biomedical literature | pubmed.ncbi.nlm.nih.gov |
| ClinicalTrials.gov | Global clinical trial registry | clinicaltrials.gov |
| International Organization for Standardization (ISO) | Medical device quality and healthcare standards | www.iso.org |
| ASTM International | Medical device testing and material standards | www.astm.org |
| Advanced Medical Technology Association (AdvaMed) | Medical devices and diagnostics industry | www.advamed.org |
| Medical Device Innovation Consortium (MDIC) | Medical device innovation and regulatory science | mdic.org |
| Biotechnology Innovation Organization (BIO) | Biotechnology industry developments | www.bio.org |
| International Federation of Pharmaceutical Manufacturers & Associations (IFPMA) | Global pharmaceutical industry | www.ifpma.org |
| U.S. Pharmacopeia (USP) | Drug quality standards and reference materials | www.usp.org |
| European Directorate for the Quality of Medicines & HealthCare (EDQM) | European pharmaceutical quality standards | www.edqm.eu |
| World Organisation for Animal Health (WOAH) | Veterinary healthcare and animal diseases | www.woah.org |
| American Hospital Association (AHA) | Hospital operations and healthcare delivery | www.aha.org |
| OECD Health | International healthcare expenditure and system statistics | www.oecd.org/health |
| World Bank Data | Healthcare expenditure and demographic indicators | data.worldbank.org |
Research Workflow & Quality Assurance
Data Collection
Verified information gathered through primary and secondary research.
Data Triangulation
Cross-validation using multiple independent data sources.
Forecast Modelling
Market estimates developed using historical trends and analytical models.
Analyst Validation
Findings reviewed by domain experts for accuracy and consistency.
Editorial & Quality Review
Final editorial, quality, and compliance checks before publication.
Final Publication
Released after successful completion of the internal review process.
Report Coverage
📊 Market Assessment
- Market Size & Forecast
- Market Segmentation
- Regional Analysis
- Growth Drivers & Challenges
- Market Dynamics
🏢 Competitive Intelligence
- Competitive Landscape
- Company Profiles
- Competitive Benchmarking
- Mergers & Acquisitions
- Market Share Analysis or Key Company Strategies
🔍 Strategic Analysis
- Value Chain Analysis
- Porter's Five Forces
- PESTLE Analysis
- Pricing Trends
- Supply-Demand Analysis
🚀 Future Outlook
- Technology Landscape
- Regulatory Landscape
- Investment & Funding Landscape
- Emerging Opportunities
- Future Market Outlook
Have a question about this report or need a custom scope?
Request Customization